SKI Market

Indian Indices

Sensex

84,679.86 -533.50
( -0.63%)

Global Indices

Nasdaq

48,441.87 -37.19
(-0.08%)

Dow Jones

6,837.99 -10.42
(-0.15%)

Hang Seng

49,445.34 -722.77
(-1.44%)

Nikkei 225

9,668.67 -82.64
(-0.85%)

Forex

USD-INR

90.53 0.34
(0.38%)

EUR-INR

106.28 0.58
(0.55%)

GBP-INR

121.02 0.27
(0.22%)

JPY-INR

0.58 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novelix Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

536565

INE314I01036

23.5671906

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

117.48

113.88

EPS(TTM)

Face Value()

Div & Yield %

0.52

Back

novelix pharmaceuticals ltd

Novelix Pharmaceuticals standalone net profit rises 307.69% in the September 2025 quarter

Nov 14,2025

Net profit of Novelix Pharmaceuticals rose 307.69% to Rs 0.53 crore in the quarter ended September 2025 as against Rs 0.13 crore during the previous quarter ended September 2024. Sales rose 818.18% to Rs 36.36 crore in the quarter ended September 2025 as against Rs 3.96 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	36.36	3.96	818
OPM %	1.93	5.30	-
PBDT	0.73	0.13	462
PBT	0.72	0.13	454
NP	0.53	0.13	308

84,679.86 -533.50 ( -0.63%)

48,441.87 -37.19 (-0.08%)

6,837.99 -10.42 (-0.15%)

49,445.34 -722.77 (-1.44%)

9,668.67 -82.64 (-0.85%)

90.53 0.34 (0.38%)

106.28 0.58 (0.55%)

121.02 0.27 (0.22%)

0.58 0.00 (0.23%)